Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis-Reference-Cited by-同舟云学术

Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis

Published:2006-01 Issue:6 Volume:47 Page:998-1005
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Ganjoo Kristen N.,An Caroline S.,Robertson Michael J.,Gordon Leo I.,Sen Joy A.,Weisenbach Jill,Li Shuli,Weller Edie A.,Orazi Attilio,Horning Sandra J.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190600563821

Reference37 articles.

1. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

2. Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma

3. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

4. First Analysis of the Completed Mabthera International (Mint) Trial in Young Patients with Low-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Addition of Rituximab to a CHOP-Like Regimen Significantly Improves Outcome of All Patients with the Identification of a Very Favorable Subgroup with IPI=O and No Bulky Disease.

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophages and angiogenesis in human lymphomas;Clinical and Experimental Medicine;2024-01-29

2. Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways;Cancers;2023-06-20

3. DLBCL 1L—What to Expect beyond R-CHOP?;Cancers;2022-03-11

4. Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth;Frontiers in Immunology;2020-12-03

5. Lymphoma Angiogenesis Is Orchestrated by Noncanonical Signaling Pathways;Cancer Research;2020-01-13